http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35687142

Outgoing Links

Predicate Object
contentType Journal Article
issn 2666-6065
pageRange 100835-
publicationName The Lancet Regional Health - Western Pacific
startingPage 100835
bibliographicCitation Wang F, Xiao W, Tang Y, Cao M, Shu D, Asakawa T, Xu Y, Jiang X, Zhang L, Wang W, Tang J, Huang Y, Yang Y, Yang Y, Tang R, Shen J, Lu H. Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial. The Lancet Regional Health - Western Pacific. 2023 Sep;38():100835. doi: 10.1016/j.lanwpc.2023.100835.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b4694e719c5116c83f31a91e0bf4407
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa1ed555b12046ba2b0913aee235b0f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65d871cf80f867c02da39f76219bbf7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb4f708dd8e13ca6b73a7ab15eb807b7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_878253af3c826d527f145571cae6208a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad7be3a1c75cd2024323374e6e3d4a66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b87654950cd1b27c6b9aa4a095fb67a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cad5410537ecf4ac862d93d4d525467
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c3c3bd7c599cba9036f23764484e89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e0d92ca9aa7433f2d17c7f3f04cd6ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53b8438ed28df0d2e6a02d965e0497dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c87bf07481946dfda29f3b3c76ffd401
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c50d57796c146eec43e1a523494b1ef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25c5e894cc4d84c8300b470cc315a1f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_254e7b4c50c8b76036fb8a9da1950fcf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31481b6b9a5d915f11be08aecdd76066
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date 202309
identifier https://doi.org/10.1016/j.lanwpc.2023.100835
https://pubmed.ncbi.nlm.nih.gov/37484496
https://pubmed.ncbi.nlm.nih.gov/PMC10362366
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/50298
https://portal.issn.org/resource/ISSN/2666-6065
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11271

Total number of triples: 36.